' INTRODUCTION
Considerable efforts in the design and synthesis of targeted nanoparticle conjugates have resulted in the generation of a wide variety of highly sensitive and selective nanoparticle-based diagnostics. [1] [2] [3] Among the advantages of using nanomaterials for diagnostic purposes are (1) the small size of the nanoparticle (1-100 nm) results in large surface-to-volume ratios, and (2) the unique, and sometimes enhanced, physical and chemical properties that some materials exhibit in the nanoregime. 1, 2, [4] [5] [6] Another important characteristic of these nanomaterials is their exceptional size-dependent properties, such as the distinct lightscattering pattern of gold nanoparticles and the discrete luminescent behavior that semiconductor quantum dots exhibit due to their size and shape. [7] [8] [9] Furthermore, the clustering and selfassembly of some of these nanoparticles induces physical changes that depend on the nature and concentration of the agents inducing the nanoassembly. 9, 10 For example, it is wellestablished that the clustering of gold nanoparticles in solution results in a cooperative interaction of the surface plasmons of the individual nanoparticles resulting in prominent changes in the solution's surface plasmon peak. 9, 10 When gold nanoparticles in solution were conjugated with noncomplementary oligonucleotides, it was observed that the color of the solution changed from red to blue in the presence of target sequences, pointing toward the use of this technique in DNA diagnostics. 11, 12 Since then, this principle has been adopted in multiple reports for the design of highly sensitive diagnostics techniques. [13] [14] [15] [16] [17] [18] [19] [20] In addition, it has been observed that when superparamagnetic iron oxide nanoparticles self-assemble in solution, the nanoparticles become more efficient at decreasing the lifetime of the proton nuclear magnetic resonance (NMR) signal of the surrounding water molecules. [21] [22] [23] This process, referred to as transverse or spin-spin relaxation, results in significant changes in the transverse or spin-spin relaxation time of bulk water protons (T 2 ) that can be measured by a simple relaxometer, NMR, or magnetic resonance imaging (MRI) instrument. This principle has allowed the design of magnetic nanoparticle conjugates (denoted as magnetic relaxation nanoswitches, MRnS) that self-assemble in solution when a specific molecular target is present and reports its presence and concentration by changing the solution T 2 value. Typically, when the iron oxide nanoparticles assemble due to the presence of a particular target, a concomitant T 2 decrease is observed. 21, [24] [25] [26] [27] In contrast, when the presence of a target or a particular enzymatic activity triggers the disassembly of a pre-existing nanoassembly, a T 2 increase is observed. 22, 23, 28 This capability allowed the design of reversible systems that can sense the presence of a target via the assembly of individual nanoparticles or the disassembly of pre-existing nanoparticle complexes.
For a target-induced assembly of magnetic nanoparticles to occur, it is plausible that the target must first bind the nanoparticles, and then via multivalent interactions, target-nanoparticle assemblies can subsequently form. Interestingly, the effect of this initial target-binding event on the T 2 value has not been reported. Hence, we hypothesized that an initial, fast binding of a target to a nanoparticle may prevent water molecules from reaching the proximity of the iron oxide nanoparticle, potentially resulting in an increase (not a decrease as observed with clustering) in T 2 values for sufficiently large targets (Scheme 1). For example, this may occur during monovalent target-nanoparticle interactions, where binding of a target to the MRnS does not cause nanoparticle target-induced aggregation. As the concentration of a monovalent target or the number of attached ligands on the MRnS increases, T 2 values could be expected to increase as well. Alternatively, in the presence of a multivalent target, clustering may take place, decreasing the T 2 value as previously reported (Scheme 1).
The absence of a comprehensive study delineating how the MRnS-target interaction (binding vs clustering) modulates T 2 values prompted us to develop MRnS that distinctively associate via binding with clinically relevant biological targets. We selected a plethora of probes, including small molecules, proteins, and nucleic acids, as well as a diverse array of targets, ranging from carbohydrates and DNA to toxins and cancer cells. In initial studies, we discovered that the chemical conjugation of a ligand to the MRnS generated a new nanosensor with noticeably diminished spin-spin relaxivity (designated r 2 and defined as
, where M is the nanoparticle molarity), indicating that its ability to efficiently reduce the lifetime of the water proton NMR signal has been partially compromised. Upon binding of a ligand to MRnS, a decrease in the r 2 value was observed for the aqueous suspension of nanoparticles. In addition, as the number of ligands conjugated on the nanoparticle surface or the molecular weight of the conjugated ligand increased, the r 2 values also decreased. For these cases, because r 2 is inversely proportional to T 2 , the T 2 values of the MRnS aqueous suspensions increased upon ligand binding. Furthermore, we discovered that the noncovalent conjugation of biomolecules to MRnS followed a similar pattern, because the T 2 values for a suspension of Protein G-conjugated MRnS increased when the number of antibodies bound to the Protein G on the nanoparticle increased. Mechanistically, we found that MRnS binding precedes nanoparticle clustering, leading to faster detection kinetics without compromising sensitivity. Hence, through MRnS binding, we were able to quantify as little as 5.3 fmol of DNA and 8 pmol of the cholera toxin B subunit (Ctb). Most importantly, we approached single cancer cell detection in 200 μL of blood through MRnS-cell binding, indicating that this diagnostic method is sensitive and clinically relevant. Overall, we demonstrate herein that (1) conjugation of a ligand or binding of a target to MRnS can cause T 2 increases, (2) MRnS binding is a kinetically faster process than clustering and most likely precedes target-MRnS aggregation, and (3) association of MRnS with their corresponding target, without clustering, achieves sensitivity that is comparable to that obtained during MRnS-target aggregation. In addition to small molecules, antibodies, toxins, nucleic acids, and mammalian cells that were detected in the present report, it is anticipated that the observed MRnS behavior should be universal during the detection of other cells and pathogenic entities. We have accounted our observed T 2 increase by proposing an extension of the outer sphere relaxation theory used to describe the T 2 decrease from the conventional MRnS-target clustering mechanism. Synthesis of Iron Oxide Nanoparticles. Both poly(acrylic acid)-and dextran-coated, iron oxide nanoparticles were synthesized using the alkaline precipitation method, as recently reported. 31, 32 Briefly, a Fe 3þ /Fe 2þ solution was rapidly mixed with an ammonium hydroxide solution for 30 s, prior to addition of the polymer solution. After synthesis, the resulting nanoparticles were washed, concentrated, and reconstituted in phosphate buffered saline (PBS, pH 7.4), using a KrosFlo Research II TFF system equipped with a 10 kDa column (Carilion-Spectrum) to remove any unreacted reagents. To incorporate Journal of the American Chemical Society ARTICLE propargyl groups to the nanoparticles, carbodiimide chemistry was used followed by magnetic separation, as previously reported.
32,33
Synthesis of Small-Molecule-Carrying MRnS Using "Click" Chemistry. To synthesize folate-and doxorubicin-conjugated nanoparticles, propargylated nanoparticles (13 mg, 1.69 mg/mL) were added to either azide-terminated folic acid or azide-terminated doxorubicin. To obtain MRnS with different numbers of folic acid ligands on their surface, we varied the stoichiometry of the ligand-to-nanoparticle concentration. For the preparation of nanoparticles conjugated with 1 folate group, 0.4 μg of folic acid (0.8 Â 10 -2 μmol) in DMSO were used, whereas for the MRnS with 45 and 120 folic acid moieties, 1.5 mg (3 Â 10 -2 mmol) and 4 mg (8 Â 10 -2 mmol) were utilized, respectively. Likewise, we used 0.05 mg (0.08 μmol) and 0.5 mg (0.8 μmol) of doxorubicin for the preparation of the doxorubicin-carrying MRnS. All reactions were initiated at room temperature in the presence of catalytic amounts of CuI (0.01 μg, 5 Â 10 -8 mmol), in 125 μL of bicarbonate buffer (pH 8.5), and further incubated for 12 h at room temperature ("click" chemistry). The final reaction mixtures were purified via magnetic separation and finally dialyzed using a 6000-8000 MW cutoff dialysis bag against deionized (DI) water and PBS.
Synthesis of Protein-Carrying Nanoparticles. For the conjugation of proteins to nanoparticles, we utilized EDC/NHS chemistry. Specifically, poly(acrylic acid)-coated nanoparticles ([Fe] = 0.25 mg/ mL) were mixed with 2 mL of MES buffer (pH 6), followed by the dropwise addition of EDC (1 mg, 0.11 mmol) and NHS (0.8 mg, 0.15 mmol). This reaction mixture was incubated for 3 min before the dropwise addition of the protein of interest (1.5 mg) in DI water (0.5 mL). The reaction continued for 30 min at room temperature under continuous mixing before overnight incubation at 4°C. To isolate the protein-carrying MRnS, we magnetically separated the reaction mixture through a 1X-PBS-equilibrated LS25 column. Conjugation of antibodies to Protein G-carrying nanoparticles (250 μL) was performed as previously reported by varying the antibody's concentration, using either 5 μg or 0.5 ng of anti-Ctb, 33, 34 resulting in nanoparticles with different valencies. Nanoparticle valency was evaluated as previously reported. 33 Synthesis of Oligonucleotide-Carrying MRnS. Conjugation of an azide-terminated 15-bp oligonucleotide (5 0 -ATGTGGTTGCTG TGT-3 0 ) to propargylated poly(acrylic acid)-coated, iron oxide nanoparticles was achieved via "click" chemistry, as previously described. 35 Briefly, 400 μL of propargylated nanoparticles was resuspended in 1100 μL of NaHCO 3 buffer (0.1 M, pH 8.4). To this, we added 200 μL of 10 mM tris(2-carboxyethyl)phosphane hydrochloride (Sigma-Aldrich) as a reducing agent. Either 2.5 or 20 μL of 6.3 M oligonucleotide solution was diluted in 80 μL of NaHCO 3 buffer (0.1 M, pH 8.4) and added to the nanoparticle solution. Reaction was initiated with the dropwise addition of 150 μL of the Cu(II) complex with tris(benzyltriazolylmethyl) amine (Sigma-Aldrich) at 10 mM, which was previously prepared in DI water and t-butanol (9:1, v:v). The reaction was incubated at room temperature under continuous mixing for 3 h, followed by overnight incubation at 4°C under constant mixing. The resulting MRnS was dialyzed against DI water using a 6000-8000 MW cutoff membrane (Spectrum), followed by magnetic separation with an LS25 MACS column (Miltenyi). Determination of MRnS oligonucleotide concentration was achieved by monitoring the absorbance at 260 and 305 nm (background), using a Nanodrop 1000 spectrophotometer (Thermo Scientific).
Characterization of the MRnS-Target State. MRnS particle diameter was determined by DLS using a PDDLS CoolBatch 40T instrument and Precision Deconvolve 32 software. For r 2 measurements, a 0.47 T mq20 NMR analyzer (Minispec, Bruker) was used, while the iron concentration was determined spectrophotometrically after acid digestion of the nanoparticles as previously reported. 24, 36, 37 All T 2 measurements were performed using a CPMG pulse-echo train with a 1.5 ms interpulse spacing (Bruker Corp., Billerica, MA). To determine the state of MRnS-target interactions (assembled or clustered), DLS was utilized, because this technique can provide information about the nanoparticles' dispersion state in solution, as opposed to other methods, like transmission electron microscopy, that require depositing the samples on a solid support followed by drying. DLS and T 2 measurements were conducted in triplicate after 30 min incubation at room temperature under continuous mixing. All measurements were performed in triplicates, unless otherwise stated. For studies with dextrancoated MRnS, an iron concentration of 0.02 μg/μL was used.
Determination of the MRnS-DNA Interaction. DNA-sensing MRnS were suspended in 0.1 M phosphate buffer (pH 7.4) containing 6 μg/mL iron. To 200 μL of this suspension was added 1 μL of target DNA (5 0 -ACACAGCAACCACAT-3 0 , University of Maryland Biopolymer and Genomics Core Facility) in phosphate buffer. The target sequence also contained several copies of the complementary sequence. Quantification of the target DNA stocks was achieved spectrophotometrically using a Nanodrop 1000 spectrophotometer. For the experiments with the B. anthracis DNA, the isolated 182 kbp pX01 and 94 kbp pX02 plasmids were used (U.S. Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD), as well as biotinylated probes complementary to their unique sequences.
Determination of the MRnS-Ctb Interaction. Lyophilized pentameric Ctb was reconstituted in DI water according to the supplier's protocol. Serial dilutions of Ctb were also prepared in DI water and stored at 4°C. To obtain Ctb in its monomeric form, aliquots of the protein stocks were subjected to 100°C for 1 h, leading to dissociation of the pentamer's subunits by disruption of noncovalent links. 38 Ctb aliquots of 5 μL were incubated with 195 μL of the Ctb MRnS working solutions ([Fe] = 1 μg/mL) at room temperature under continuous mixing at 350 rpm for 30 m, followed by DLS and T 2 measurements.
Magnetic-Relaxation-Mediated Detection of Cancer Cells.
Folate-receptor-positive, lung cancer cells A549 from the ATCC were grown according to the supplier's procedures. After harvesting, the cells were quantified using the hemocytometer method, followed by preparation of stock cellular suspensions in 1X PBS, 5% PBS-diluted blood. For magnetic relaxation studies, 10 μL aliquots of cell suspensions were incubated with 190 μL of folate-carrying nanoparticle working solution ([Fe] = 10 μg/mL) at room temperature. T 2 values were measured after 15 min of incubation at room temperature with 400 rpm shaking.
' RESULTS
Our initial investigations examined whether chemical conjugation of ligands to MRnS affects the nanoparticle's overall size and relaxivity. Unconjugated MRnS had a diameter of 75 nm with an r 2 of 287 mM -1 s -1 (Table 1 ). Conjugation of folate or doxorubicin (both small molecules) resulted in r 2 decreases and only minimal changes in particle diameter (Table 1) . To elucidate whether this is observed for other molecular targets (Table 1) . Hence, the observed r 2 decreases were not attributed to changes in the particle diameter due to declustering of pre-existing MRnS clusters (Supporting Information Figure  1 ). It should be noted that conjugation of a large protein (Avidin or Con A) had a more pronounced effect on r 2 than did conjugation of folate or doxorubicin.
We next investigated whether the number of ligands decorating the nanoparticle surface affects r 2 relaxivity. We utilized three different model systems, ranging from small molecules to a macromolecule. First, valency-grafted, folate-carrying MRnS demonstrated a ligand concentration-dependent decrease in r 2 ( Table 2 and Figure 1) . Specifically, the higher the nanoparticle valency (the number of ligands bound per nanoparticle) the lower the r 2 value. Likewise, this was observed in valency-engineered MRnS with doxorubicin moieties attached to their surfaces (Table 2) . Interestingly, when a 15-bp oligonucleotide was attached to the nanoparticle, a drastic reduction in r 2 was observed ( Table 2 ). This may be attributed to differences in ligand characteristics, such as their overall size and molecular weight.
Considering that chemical conjugation of a ligand to MRnS promoted decreases in the r 2 relaxivity and spin-spin water proton relaxation rate (1/T 2 ), we investigated whether noncovalent associations between the nanoparticles and a molecule could have similar effects. Specifically, as T 2 is measured during magnetic relaxation studies, we recorded this parameter and anticipated increases in its values, because T 2 is inversely proportional to both the water proton relaxation rate (1/T 2 ) and the r 2 relaxivity. We used dextran-coated MRnS and Con A, a protein that has high affinity toward carbohydrates, including dextran's monomeric glucose building block. 13, 29 At low protein concentrations, T 2 values increased, with minor changes in the nanoparticle size distribution due to protein binding (Table 3 and Supporting Information Figure 2) . However, at higher Con A levels, these T 2 values decreased, apparently because of the formation of extensive MRnS assemblies (Table 3 and Supporting Information Figure 2 ). Considering these data, we examined whether there were any kinetic differences between the two interaction mechanisms. We monitored T 2 values over time during the binding or clustering of MRnS and Con A (Figure 2 ) and found that binding occurred much faster than clustering. For binding in particular, T 2 values quickly reached a plateau ∼7 min after addition of low levels of Con A (Figure 2A) . Alternatively, the Con A-induced clustering of MRnS progressed slowly, finally reaching its end point after ∼30 min ( Figure 2B ). These results indicate that recognition of a molecular target by MRnS via binding is a faster process than the target-induced clustering of MRnS.
Apart from proteins, nucleic acids are an important class of biomarkers. Thus, nucleic-acid-sensing MRnS has been previously reported for the detection of DNA, mRNA, and Journal of the American Chemical Society ARTICLE telomerase activity. 21, 39, 40 Although in those reports the T 2 changes were attributed to nanoparticle clustering, we examined whether the levels of the nucleic acid target may differentially affect T 2 . Interestingly, we found that T 2 values increased at low DNA levels, whereas at higher target concentrations, nanoparticle aggregation caused T 2 decreases (Table 4) . Furthermore, we investigated whether this trend is valid during the detection of more extensive nucleic acid targets, such as pathogenic plasmids found in the B. anthracis bacteria causing anthrax. 41, 42 With the B. anthracis pX01 and pX02 plasmids, the MRnS behaved similarly as with the oligonucleotide (above), where the T 2 values increased significantly at 2.1 fmol of plasmid but decreased at 210 fmol of plasmid.
After discovering that binding of a ligand or a target moiety to MRnS induced T 2 increases, we investigated whether the noncovalent bonding of antibodies to MRnS can have similar effects. It was expected that as different antibodies bind to MRnS, a concomitant increase in T 2 would be observed, regardless of the nature of chemical bonding. To examine this hypothesis, we utilized Protein G-carrying MRnS and IgG antibodies (rabbit anti-Ctb polyclonal IgG). It is well established that Protein G noncovalently associates with the F c region of immunoglobulins, facilitating the conjugation of the antibody to nanoparticles and various substrates. Our results indicated that attachment of antibodies to the MRnS increased T 2 values ( Figure 3A) . Specifically, quantification of the number of antibodies bound per nanoparticle revealed that the T 2 values increased with the number of antibodies bound. Additionally, DLS studies indicated a complete absence of MRnS aggregation. However, considering the IgG's dimensions (14.2 nm Â 8.5 nm Â 3.8 nm), [43] [44] [45] [46] the corresponding changes in nanoparticle size can be attributed to antibody-MRnS binding ( Figure 3B ). These findings further corroborated the hypothesis that binding between a molecular entity and MRnS results in a new nanoparticle with lower r 2 relaxivity.
Subsequently, we utilized an anti-Ctb MRnS to examine its interaction with its Ctb target. Because Ctb plays a critical role in cholera intoxication by facilitating the toxin's entry into intestinal microvilli, detecting this toxin subunit can prevent cholera intoxications. 47, 48 During infection, Ctb exists in its native form as a 60 kDa homopentamer. However, during transcription of the cholera toxin genes or upon heat treatment of the homopentamer, Ctb can be found as a stable monomer, which preserves the tertiary structure of the homopentamer's subunits. 38 Therefore, we anticipated that the anti-Ctb MRnS could sense Ctb in its pentameric or monomeric form, as the polyclonal antibody recognizes shared epitopes found on both Ctb forms. Furthermore, we hypothesized that discrete diagnostic profiles and changes in T 2 values would be observed during detection of the Ctb pentamer and monomer. We rationalized that the Ctb monomer, a monovalent target, can only result in MRnS binding, whereas the Ctb pentamer may be able to facilitate MRnS clustering. Indeed, addition of Ctb induced distinct transformations in T 2 values and nanoparticle diameter. Specifically, monomeric Ctb (16 pmol) associated with MRnS, facilitating both an increase in the T 2 and a small change in the nanoparticle size (Table 5 ). On the other hand, addition of identical concentrations of pentameric Ctb led to a decrease in T 2 value, with the simultaneous emergence of a significant population of MRnS clusters as monitored with DLS.
We also studied whether the two MRnS-target interaction mechanisms yield different analyte detection kinetics by using the Ctb-sensing MRnS for the quantification of the Ctb monomer and pentamer. Our results indicate that binding of the monomer to MRnS resulted in a linear dose-dependent increase in T 2 , with a detection threshold of 8 pmol having a corresponding T 2 that significantly differed from the experimental control (0 pmol) ( Figure 4A ). On the other hand, clustering of the Ctb pentamer with MRnS decreased T 2 values, with a minimum detection limit of 16 pmol ( Figure 4B ). Overall, these data suggest that the MRnS T 2 switching mode is universal and governed by the MRnS-target interaction mechanism. a At low target concentrations, the T 2 increases, but it decreases at higher concentrations due to extensive assembly formation (mean ( SE). ' DISCUSSION Over the last two decades, nanoparticles have been shown to display some unique, and sometimes remarkable, properties in solution.
Journal of the American Chemical Society
1,2,4-6 MRnS particles are no exception, particularly in cases of inducing measurable changes in NMR (and MRI) signals. It has been demonstrated that MRnS becomes significantly more efficient at decreasing the lifetime of the proton NMR signal for surrounding water molecules upon targetinduced nanoparticle clustering, resulting in measurable decreases in water proton T 2 values. 23 Additionally, subsequent studies revealed that when the presence of a target or particular enzymatic activity triggers the disassembly of a pre-existing supramolecular assembly, an increase in this T 2 value is observed. 21 We have demonstrated that under certain stoichiometric conditions, MRnS particles can also increase T 2 values upon target binding and that the previously reported decrease in T 2 values induced upon MRnS-target clustering is also stoichiometrically controlled. Finally, we have also shown that the conjugation of a molecule of sufficient size to the MRnS can result in a sensor with slightly lower r 2 relaxivity toward water protons relative to the unconjugated MRnS. Also, this decrease in r 2 relaxivity is inversely proportional to the number of molecules populating the MRnS surface. We have developed a general hypothesis to account for all these observations based on the theory used to describe the relaxation of water protons when interacting with superparamagnetic nanoparticles.
The MRnS detection of target molecules is based solely on the water proton NMR signal and the accurate measurement of its lifetime. Detection is possible because NMR relaxation is considerably accelerated when the spins of these protons couple with the larger magnetic moments of the electrons within the MRnS superparamagnetic core. Thus, MRnS-target interactions can profoundly affect this coupling. The earliest investigations of paramagnetic-induced, proton relaxation concentrated on paramagnetic cations in aqueous solutions. Today there are two models, the inner sphere model and the outer sphere model, used to describe the relaxation mechanisms involving paramagnetic cations and molecular entities containing paramagnetic and superparamagnetic centers. Inner sphere theory accounts for the exchange of water molecules between the first coordination sphere of the cations and the bulk solvent. On the other hand, the outer sphere theory describes the relaxation induced by the diffusion of water molecules through the magnetic field gradients immediately surrounding the hydrated paramagnetic cation. Although both mechanisms can occur simultaneously, one usually dominates over the other to account for the observed relaxation. Inner sphere contributions usually dominate proton relaxation in solutions of paramagnetic cations. 50 However, for aqueous solutions of superparamagnetic nanoparticles, the water proton T 2 decrease observed upon MRnS-target clustering is well described by the outer sphere theory. 30 The iron oxide cores of the nanoparticles become magnetized when placed within an external magnetic field, such as that of an NMR or MRI instrument. The combined electron spins in the core appear to produce a single, large magnetic dipole that creates a local field gradient and, therefore, an inhomogeneity in the external magnetic field. The protons of water molecules diffusing through this inhomogeneity precess at a different frequency, dephasing their spins and leading to a decrease in the water proton T 2 value. The outer sphere theory dictates that this T 2 decrease is directly proportional to the nanoparticle cross-sectional area. 51 It has been proposed that when individual MRnS cluster upon target binding and the effective cross-sectional area of the cluster becomes larger, they become more efficient at dephasing the spins of surrounding water protons, leading to an enhancement of the rate of transverse relaxation (1/T 2 ) and a decrease in the associated T 2 value. 30, 52 Interestingly, the spin-lattice relaxation time (T 1 ) of water protons appears to be largely unaffected by nanoparticle clustering. 23 The outer sphere model can be readily extended to account for the apparent effects of MRnS molar concentration, [MRnS] , that of the molecules used to provide target-binding moieties to the MRnS, [Bind] , and that of the target molecule, Table 1 , yields complexes of MRnS bound to target-binding moieties. The bound moieties physically obstruct the access of water molecules to the MRnS outer spheres, causing a small decrease in r 2 , and therefore an increase in T 2 to a value closer to that of bulk water. Moreover, as shown by Table 2 Target] ). The excess of target and binding moiety molecules relative to the MRnS allows the formation of very extensive supramolecular assemblies comprising large numbers of MRnS particles, and even larger numbers of target molecules (MRnS i :Target j , j > i . 1). These assemblies are the conventional nanoparticle agglomerates, or clusters, that are known to decrease T 2 values. It may be possible for water molecules to slowly diffuse through this supramolecular assemblies, effectively removing them from the solution for a significant amount of time and placing them in an environment characterized by a high density of MRnS outer spheres. We have illustrated this possibility in Scheme 2 by including water molecules inside the supramolecular assembly. For target-induced clustering of MRnS to occur, at least two different types of target molecules must be recognized by a single MRnS, or a single target molecule must contain more than one binding site for the MRnS particle. The former case is exemplified in Figure 4 by the simultaneous MRnS binding of two different plasmid fragment targets, while the latter is demonstrated by the different interactions between MRnS particles and Ctb proteins summarized in Table 5 . The product from the binding of MRnS and Ctb monomers is a new particle only slightly larger than the original MRnS particle, while the interaction between MRnS and Ctb pentamers generates a new molecular assembly ∼4 times larger than that of the original nanoparticle.
' CONCLUSIONS
We have demonstrated that, in addition to the interaction mechanism of molecular clustering resulting in supermolecular assemblies and T 2 decreases, MRnS can interact with their target molecules to form constructs, which increase T 2 values as well. This newly discovered interaction mechanism exhibits substantially faster kinetics in comparison to clustering, leading to faster T 2 changes and target detection. Furthermore, we have demonstrated that the incorporation of ligands or target-binding moieties onto MRnS generates a new nanoparticle with lower r 2 values, and therefore increased T 2 values, relative to that of the original nanoparticle. We attribute the T 2 increases, in both cases, as the consequence of the added ligands, binding moieties, or target molecules partially obstructing the diffusion of solvent water molecules through the outer relaxation sphere of the superparamagnetic MRnS. Consistent with this explanation, we have shown that the r 2 decrease from incorporating ligands or target-binding moieties is inversely proportional to the molecular weight of the ligand or moiety used, and the number of ligands or moieties decorating the nanoparticle surface as well. As the new nanoparticle-target binding mechanism and its concomitant T 2 increases for both protein and DNA targets provide faster detection kinetics, the adoption of this mechanism into new clinical and field detection applications should be anticipated, leading to the emergence of more sensitive nanoparticle-based diagnostic assays. 
